SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Straumann Holding AG SAUHY OTC

Other OTC • Healthcare • Medical - Instruments & Supplies • CH • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Straumann Holding AG (SAUHY) is a Medical - Instruments & Supplies company in the Healthcare sector, currently trading at $11.28. It has a SharesGrow Score of 69/100, indicating a above average investment profile with 4 out of 7 criteria passed.

Financials: revenue is $2.5B, +2.4%/yr average growth. Net income is $342M, growing at +0.8%/yr. Net profit margin is 13.7% (healthy). Gross margin is 68.6% (-4.7 pp trend).

Balance sheet: total debt is $651M against $2.2B equity (Debt-to-Equity (D/E) ratio 0.3, conservative). Current ratio is 2.21 (strong liquidity). Debt-to-assets is 17%. Total assets: $3.8B.

Analyst outlook: 1 / 1 analysts rate SAUHY as buy (100%) — strong consensus.

SharesGrow 7-Criteria breakdown: Value 15/100 (Fail), Growth 45/100 (Partial), Past 100/100 (Pass), Health 100/100 (Pass), Moat 71/100 (Pass), Future 100/100 (Pass), Income 55/100 (Partial).

SAUHY SharesGrow Score Overview

69/100

SharesGrow Score

Above average fundamentals

View full scorecard →

VALUE 15/100

Valuation — P/E, PEG, Forward PEG

GROWTH 45/100

Financials — average growth

PAST 100/100

strong — trend

HEALTH 100/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 71/100

Gross margin is + market cap

FUTURE 100/100

Analyst outlook — as buy

INCOME 55/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — SAUHY

SAUHY trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.

View details →

SAUHY: +2.4%/yr revenue is, +0.8%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

SAUHY: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.

View details →

Balance sheet SAUHY: Debt-to-Equity (D/E) ratio 0.3 (conservative), Current ratio is 2.21 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

SAUHY: Gross margin is 68.6% (-4.7 pp trend), $18B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 71/100. ≥ 70 = Pass.

View details →

Analyst outlook: 1 / 1 analysts rate SAUHY as buy (100%). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.

View details →

SAUHY: Net profit margin is 13.7%. thin (5-15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range9.44-14.18

Volume3K

Avg Volume (30D)244.19K

Market Cap$17.99B

Beta (1Y)1.42

Dividend Yield$0.2100

Share Statistics

EPS (TTM)0.21

Shares Outstanding$1.6B

IPO Date2014-12-19

Employees11,342

CEOGuillaume Daniellot

Financial Highlights & Ratios

Revenue (TTM)$2.49B

Gross Profit$1.71B

EBITDA$524.32M

Net Income$341.91M

Operating Income$524.32M

Total Cash$490.13M

Total Debt$651.46M

Net Debt$175.49M

Total Assets$3.82B

Price / Earnings (P/E)53.7

Price / Sales (P/S)7.23

Analyst Forecast

Rating ConsensusBuy

Analysts Covering1

Buy 100% Hold 0% Sell 0%

Company Info

CountryCH

ExchangeOther OTC

CurrencyUSD

ISINUS86317T1034

Price Chart

SAUHY

Straumann Holding AG ↗ · Other OTC

Healthcare • Medical - Instruments & Supplies

9.44 52WK RANGE 14.18

People Also View

EssilorLuxottica S.A.

EssilorLuxottica S.A.

HOYA Corporation

Sysmex Corporation

Carl Zeiss Meditec AG

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message